IU Ventures makes $475,000 in renewed investments in emerging health, technology companies
Apexian is a clinical-stage biotech company led by an IU professor, and NuCurrent is a wireless technology company led by an IU alum.
Apexian is a clinical-stage biotech company led by an IU professor, and NuCurrent is a wireless technology company led by an IU alum.